FDA Inspection 1252042 — Janice Faulknor, M.D.
The FDA completed an inspection of Janice Faulknor, M.D. on Sep 19, 2024 in North York. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 19, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- North York (Canada)
Additional Details
Clinical BA/BE